Serum Anti-Apo B Antibody Level as Residual CVD Marker in DM Patients under Statin Treatment

Aim: In the pathogenesis of atherosclerosis, autoantibodies have two-facedness of progression and protection. Previous reports have indicated that low autoantibody levels against apolipoprotein B-100 (apo B-100) could increase the risk of atherosclerotic cardiovascular diseases (CVD) in healthy subj...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Hiroyasu, Kawamura, Mari, Kochi, Ikoi, Imai, Minami, Murata, Yukie, Suzuki, Toshinobu, Chen, Yingchao, Hashimoto, Kunihiko, Kihara, Shinji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6800396/
https://www.ncbi.nlm.nih.gov/pubmed/30867375
http://dx.doi.org/10.5551/jat.46797

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6800396/
https://www.ncbi.nlm.nih.gov/pubmed/30867375
http://dx.doi.org/10.5551/jat.46797

Ejemplares similares